# Wellington Management's Pharma Investments: 11 Startups in Its Portfolio (2026) > The 11 Pharma startups Wellington Management has backed, by stage: $2.2B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/wellington-management-pharma-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 3 - [Zenas BioPharma](https://millionrounds.com/company/zenas-biopharma) - [Angitia Biopharmaceuticals](https://millionrounds.com/company/angitia-biopharmaceuticals) - [Avalyn Pharma](https://millionrounds.com/company/avalyn-pharma) ## Series A 3 - [Korsana Biosciences](https://millionrounds.com/company/korsana-biosciences) - [Helicore Biopharma](https://millionrounds.com/company/helicore-biopharma) - [Caldera Therapeutics](https://millionrounds.com/company/caldera-therapeutics) ## Stage not reported 3 - [Edgewise Therapeutics](https://millionrounds.com/company/edgewise-therapeutics) - [Day One Biopharmaceuticals](https://millionrounds.com/company/day-one-biopharmaceuticals) - [Ventyx Biosciences](https://millionrounds.com/company/ventyx-biosciences) ## Series B 2 - [*CT* Crystalys Therapeutics](https://millionrounds.com/company/crystalys-therapeutics) - [Metsera](https://millionrounds.com/company/metsera) ## Segment by segment ### Series C and later 3 startups · $650M raised - [**Zenas BioPharma**](https://millionrounds.com/company/zenas-biopharma) Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients. United States $420M - [**Angitia Biopharmaceuticals**](https://millionrounds.com/company/angitia-biopharmaceuticals) Angitia Biopharmaceuticals is a clinical-stage biotechnology company founded in 2018, dedicated to developing innovative therapies United States $130M - [**Avalyn Pharma**](https://millionrounds.com/company/avalyn-pharma) Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases. United States $100M ### Series A 3 startups · $633M raised - [**Korsana Biosciences**](https://millionrounds.com/company/korsana-biosciences) Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s. United States $530M - [**Helicore Biopharma**](https://millionrounds.com/company/helicore-biopharma) Helicore Biopharma is a private biopharmaceutical company based in San Mateo, California, focused on developing innovative weight- United States $65M - [**Caldera Therapeutics**](https://millionrounds.com/company/caldera-therapeutics) Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD). United States $38M ### Stage not reported 3 startups · $402M raised - [**Edgewise Therapeutics**](https://millionrounds.com/company/edgewise-therapeutics) Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization. United States $200M - [**Day One Biopharmaceuticals**](https://millionrounds.com/company/day-one-biopharmaceuticals) Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases. United States $175M - [**Ventyx Biosciences**](https://millionrounds.com/company/ventyx-biosciences) Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders. United States $27M ### Series B 2 startups · $550M raised - [*CT* **Crystalys Therapeutics**](https://millionrounds.com/company/crystalys-therapeutics) United States $335M - [**Metsera**](https://millionrounds.com/company/metsera) Metsera operates as a clinical-stage biopharmaceutical company. United States $215M **How this map is made.** Every startup here works in Pharma and has raised money in a round we track that names Wellington Management as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Wellington Management's Biotech portfolio** 62 startups · $16B](https://millionrounds.com/portfolio-maps/wellington-management-biotech-portfolio)[Sector portfolio **Wellington Management's AI portfolio** 26 startups · $67B](https://millionrounds.com/portfolio-maps/wellington-management-ai-portfolio)[Sector portfolio **Wellington Management's Fintech portfolio** 22 startups · $15B](https://millionrounds.com/portfolio-maps/wellington-management-fintech-portfolio)[Sector portfolio **Wellington Management's Healthtech portfolio** 12 startups · $3.2B](https://millionrounds.com/portfolio-maps/wellington-management-healthtech-portfolio)[Co-investors **Who invests with Wellington Management** 257 co-investors](https://millionrounds.com/portfolio-maps/wellington-management-co-investors)[Portfolio map **Wellington Management portfolio map** 170 startups · $127B](https://millionrounds.com/portfolio-maps/wellington-management-portfolio-map) ## Raising from investors like Wellington Management? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)